Safety Profile of Eslicarbazepine Acetate as Add-On Therapy in Adults with Refractory Focal-Onset Seizures: From Clinical Studies to 6 Years of Post-Marketing Experience
Crossref DOI link: https://doi.org/10.1007/s40264-017-0576-4
Published Online: 2017-07-27
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gama, Helena
Vieira, Mariana
Costa, Raquel
Graça, Joana
Magalhães, Luís M.
Soares-da-Silva, Patrício
License valid from 2017-07-27